Document is current
Any future updates will be listed below
-
Authors
Ben-Tal, Tom
Pogodin, Ilana
Botvinnik, Alexander
Lifschytz, Tzuri
Heresco-Levy, Uriel
Lerer, Bernard https://orcid.org/0000-0002-9914-632X
-
Funding
Funding for this research was provided by:
Negev Labs
- License Information
-
More Information
Article History
Received: 16 April 2025
Revised: 24 April 2025
Accepted: 9 June 2025
First Online: 13 June 2025
Competing interests
: PCT WO 2024/052895 A1 (Inventors: BL, UHL), submitted by Hadasit Medical Research and Development Ltd and Ezrath Nashim - the Rabanit Herzog Memorial Hospital discloses SP-NMDAR modulator combination therapy for psychiatric and other disorders.
: Experiments were approved by the Authority for Biological and Biomedical Models, Hebrew University of Jerusalem, Israel (Animal Care and Use Committee Approval Numbers: MD-22-17000-4 and MD-24-17494-4). All methods were performed in accordance with the relevant guidelines and regulations and all efforts were made to minimize animal suffering and the number of animals used.
